Dana-Farber/Harvard Cancer Center — Boston, Massachusetts

Dana-Farber/Harvard Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber/Harvard Cancer Center has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Intracranial Meningioma, Retroperitoneal Sarcoma, Liposarcoma.

Sponsors: RTOG Foundation, Inc., European Organisation for Research and Treatment of Cancer - EORTC, Seattle Children's Hospital.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber/Harvard Cancer Center?

Dana-Farber/Harvard Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber/Harvard Cancer Center conducted?

Dana-Farber/Harvard Cancer Center has 9 clinical trials on record, with 3 currently active. Their work covers Intracranial Meningioma, Retroperitoneal Sarcoma, Liposarcoma.

Is Dana-Farber/Harvard Cancer Center accredited by Crixeo Health?

Yes — Dana-Farber/Harvard Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana-Farber/Harvard Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.